Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New mouse model of multiple sclerosis points to NLRX1 as a treatment target

March 13, 2019

Friedrich-Alexander-Universitaet Erlangen-Nuernberg and collaborators patent MOR agonists

March 13, 2019

Servier and Oncodesign enter LRRK2 inhibitor R&D collaboration

March 13, 2019

Novartis initiates phase II study of MIJ-821 in patients with treatment-resistant depression

March 13, 2019

Sig1R identified as upstream modulator of canonical autophagy

March 13, 2019

Characterization of novel negative allosteric modulators of metabotropic glutamate mGlu5 receptor

March 12, 2019

ACADIA Pharmaceuticals divulges 5-HT2A receptor ligands

March 12, 2019

Promising interim data reported from first cohort of SUNRISE-PD study of AXO-Lenti-PD

March 12, 2019

Topline results from first-in-human study of TLC-590 for postsurgical pain

March 11, 2019

AQAMAN: Heroic inhibitor restrains polyQ aggregation

March 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...
Menstrual ‘footprints’ may act as broad personal health markers
BioWorld
WAVES, an algorithm designed to extract menstrual-cycle metrics from physiological signals such as basal body temperature, which oscillates with sex hormones,...